Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

v2.4.0.8
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
 6 Months Ended
Feb. 28, 2014
Feb. 28, 2013
Operating Activities    
Net earnings $ 77,429 $ 64,778
Adjustments to reconcile net earnings to cash provided by operating activities:    
Depreciation and amortization 31,965 28,898
Net gain on disposal of business (26,339) 0
Deferred income tax benefit (11,064) (6,018)
Stock-based compensation expense 10,612 7,128
Amortization of debt discount and debt issuance costs 983 992
Other non-cash adjustments (743) (172)
Sources (uses) of cash from changes in components of working capital and other:    
Accounts receivable 4,769 (3,721)
Inventories (21,783) (4,152)
Prepaid expenses and other assets (1,071) (1,204)
Trade accounts payable (12,835) (22,281)
Income taxes payable (13,399) (2,722)
Accrued compensation and benefits 3,673 (12,427)
Other accrued liabilities (5,314) (8,776)
Net cash provided by operating activities 36,883 40,323
Investing Activities    
Capital expenditures (22,226) (11,726)
Proceeds from sale of property, plant and equipment 2,008 1,177
Proceeds from sale of business, net of transaction costs 243,386 0
Business acquisitions, net of cash acquired 0 (83)
Net cash provided by (used in) investing activities 223,168 (10,632)
Financing Activities    
Net repayments on revolver (125,000) 0
Principal repayments on term loan 0 (2,500)
Purchase of treasury shares (109,095) (8,821)
Stock option exercises and related tax benefits 25,803 10,772
Payment of contingent acquisition consideration (753) (1,350)
Cash dividend (2,919) (2,911)
Net cash used in financing activities (211,964) (4,810)
Effect of exchange rate changes on cash 2,944 (2,242)
Net increase in cash and cash equivalents 51,031 22,639
Cash and cash equivalents – beginning of period 103,986 68,184
Cash and cash equivalents – end of period $ 155,017 $ 90,823